Safety and immunogenicity of a live-attenuated chikungunya virus vaccine in adolescents: final results from a 12-month, double-blind, randomised, placebo-controlled, phase 3 trial in endemic areas of Brazil.

Vera Buerger, Andrea Pfeiffer, Petra Schoengrundner, Jutta Seebacher, Romana Hochreiter, Karin Kosulin, Oliver Zoihsl, Petronela Weisova, Robert Mader, Ana Paula Loch, Eolo Morandi, Mauricio Lacerda Nogueira, Carlos Alexandre Antunes de Brito, Julio Croda, Mauro Martins Teixeira